AHSG and metabolic dysfunction-associated steatotic liver disease: However, we emphasize that ours is a comparative study specifically aimed at exploring the relationship of NAFLD and Fetuin-A with clinically relevant symptomatic atherosclerosis affecting different arterial sites.